AIDS activists urged drug companies and regulators on Tuesday not to stop studies aimed at finding out if antiretroviral drugs increase the risk of heart disease and other complications.
Several studies into the side effects of highly active antiretroviral therapy (HAART) were launched in 1999 at the request of the European Medicines Evaluation Agency after reports of numerous metabolic complications.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!